Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron A Adelman

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|October 7, 2014
Cataract formation following vitreoretinal proceduresHao Feng, Ron A Adelman
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 11, 2008
Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization?Fang Lu, Ron A Adelman
Seminars in Ophthalmology|July 13, 2012
Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum: five-year follow-upNazlee Zebardast, Ron A Adelman
American Journal of Ophthalmology|July 3, 2009
A study of interactions between pharmaceutical representatives and ophthalmology traineesYue Wang, Ron A Adelman
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 18, 2012
Microbial spectrum and resistance patterns in endophthalmitis: a 21-year (1988-2008) review in northeast United StatesXuejing Chen, Ron A Adelman
International Ophthalmology Clinics|September 8, 2012
Imaging for sympathetic ophthalmia: impact on the diagnosis and managementClaudia Castiblanco, Ron A Adelman
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 4, 2011
The treatment of recurrent central serous chorioretinopathy with intravitreal bevacizumabShelly T Lee, Ron A Adelman
Journal of Vitreoretinal Diseases|November 14, 2024
Trends in Medicare Reimbursement and Service Volume of Vitreoretinal Procedures: 2000 to 2021Eric S Li, Ron A Adelman
Clinical Ophthalmology (Auckland, N.Z.)|October 5, 2013
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathyShaheen P Karim, Ron A Adelman
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 17, 2008
Sympathetic ophthalmiaClaudia Patricia Castiblanco, Ron A Adelman
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Clinical Ophthalmology (Auckland, N.Z.)|October 7, 2014
Cataract formation following vitreoretinal proceduresHao Feng, Ron A Adelman
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 11, 2008
Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization?Fang Lu, Ron A Adelman
Seminars in Ophthalmology|July 13, 2012
Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum: five-year follow-upNazlee Zebardast, Ron A Adelman
American Journal of Ophthalmology|July 3, 2009
A study of interactions between pharmaceutical representatives and ophthalmology traineesYue Wang, Ron A Adelman
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 18, 2012
Microbial spectrum and resistance patterns in endophthalmitis: a 21-year (1988-2008) review in northeast United StatesXuejing Chen, Ron A Adelman
International Ophthalmology Clinics|September 8, 2012
Imaging for sympathetic ophthalmia: impact on the diagnosis and managementClaudia Castiblanco, Ron A Adelman
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 4, 2011
The treatment of recurrent central serous chorioretinopathy with intravitreal bevacizumabShelly T Lee, Ron A Adelman
Journal of Vitreoretinal Diseases|November 14, 2024
Trends in Medicare Reimbursement and Service Volume of Vitreoretinal Procedures: 2000 to 2021Eric S Li, Ron A Adelman
Clinical Ophthalmology (Auckland, N.Z.)|October 5, 2013
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathyShaheen P Karim, Ron A Adelman
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 17, 2008
Sympathetic ophthalmiaClaudia Patricia Castiblanco, Ron A Adelman
Pageof 12